{
    "title": "Novo Nordisk India head eyes 2026 Wegovy launch, warns against copycats",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12574083/Novo-Nordisk-India-head-eyes-2026-Wegovy-launch-warns-against-copycats.html",
    "date": "2023-09-29",
    "keywords": [
        "wegovy",
        "drug",
        "india",
        "novo",
        "demand",
        "obesity",
        "supply",
        "company",
        "shrotriya",
        "time",
        "ecosystem",
        "dhanya",
        "skariachan",
        "bengaluru",
        "country",
        "lot",
        "horizon",
        "action",
        "germany",
        "treatment",
        "copycat",
        "pricing",
        "drugmaker",
        "nordisk",
        "blockbuster",
        "official",
        "market",
        "opportunity",
        "online",
        "area",
        "director",
        "healthcare",
        "till",
        "surgery",
        "right",
        "interview",
        "kind",
        "chain",
        "transportation",
        "patent",
        "ingredient",
        "semaglutide",
        "month",
        "point",
        "price",
        "innovation",
        "work",
        "access",
        "injection",
        "weightloss",
        "date",
        "record",
        "ozempic",
        "lillys",
        "mounjaro",
        "class",
        "glp1",
        "receptor",
        "digestion",
        "body",
        "study",
        "benefit",
        "uk",
        "enough",
        "prevalence",
        "article",
        "journal",
        "lancet",
        "family",
        "health",
        "survey",
        "continuity",
        "editing",
        "gershberg",
        "sonali",
        "paul"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}